Titan Medical signs development and licence agreements with Medtronic
Titan Medical entered development and licence agreements with Medtronic covering robotic-assisted surgical technologies and selected intellectual property.
Evidence notes
- Titan announced the agreements on June 4, 2020, with the contractual effective date recorded as June 3.
- The development programme covered robotic-assisted surgical technologies intended for use by both companies.
- Medtronic committed milestone payments of up to US$31 million for licensed technologies, while a separate IP licence carried an upfront US$10 million payment.